Home/Filings/4/0001209191-24-000339
4//SEC Filing

Charlton Ralph William III 4

Accession 0001209191-24-000339

CIK 0001683553other

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 4:10 PM ET

Size

5.1 KB

Accession

0001209191-24-000339

Insider Transaction Report

Form 4
Period: 2023-12-29
Charlton Ralph William III
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2023-12-29$0.98/sh+9,361$9,15055,373 total
Footnotes (1)
  • [F1]Shares acquired by the Reporting Person pursuant to the Issuer's 2020 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). The Reporting Person acquired the maximum shares allowable pursuant to Section 423 of the Internal Revenue Code.

Issuer

SPRUCE BIOSCIENCES, INC.

CIK 0001683553

Entity typeother

Related Parties

1
  • filerCIK 0001919397

Filing Metadata

Form type
4
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 4:10 PM ET
Size
5.1 KB